content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: ORBIMED CAPITAL LLC -->
            <cik>0001157524</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001657312</issuerCik>
        <issuerName>Verona Pharma plc</issuerName>
        <secFileNumber>001-38067</secFileNumber>
        <issuerAddress>
          <com:street1>3 More London Riverside</com:street1>
          <com:city>LONDON</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SE1 2RE</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>981489389</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>The Biotech Growth Trust PLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>American Depository Shares</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Themis Trading LLC</name>
          <address>
            <com:street1>10 Town Square, Suite 100</com:street1>
            <com:city>Chatham</com:city>
            <com:stateOrCountry>NJ</com:stateOrCountry>
            <com:zipCode>07928</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>311598</noOfUnitsSold>
        <aggregateMarketValue>6403338.90</aggregateMarketValue>
        <noOfUnitsOutstanding>75622575</noOfUnitsOutstanding>
        <approxSaleDate>03/09/2023</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>American Depository Shares</securitiesClassTitle>
        <acquiredDate>07/17/2020</acquiredDate>
        <natureOfAcquisitionTransaction>public offering</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>666667</amountOfSecuritiesAcquired>
        <paymentDate>07/17/2020</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>The Biotech Growth Trust PLC</name>
          <address>
            <com:street1>c/o OrbiMed Capital LLC</com:street1>
            <com:street2>601 Lexington Avenue, 54th Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>American Depository Shares</securitiesClassTitle>
        <saleDate>12/22/2022</saleDate>
        <amountOfSecuritiesSold>229556</amountOfSecuritiesSold>
        <grossProceeds>4997434.12</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>Additional sales in the last three months by The Biotech Growth Trust PLC (c/o OrbiMed Capital LLC 601 Lexington Avenue, 54th Floor, New York, NY 10022) of American Depository Shares on 12/23/2022. 125,513 American Depository Shares were sold for gross proceeds of $2,866,716.92. OrbiMed Capital LLC is the portfolio manager of The Biotech Growth Trust PLC.</remarks>
      <noticeSignature>
        <noticeDate>03/09/2023</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, portfolio manager for The Biotech Growth Trust PLC</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4018}]
text: 144
  0001157524
  XXXXXXXX
  LIVE
  0001657312
  Verona Pharma plc
  001-38067
  3 More London Riverside
  LONDON
  X0
  SE1 2RE
  981489389
  The Biotech Growth Trust PLC
  Shareholder
  American Depository Shares
  Themis Trading LLC
  10 Town Square, Suite 100
  Chatham
  NJ
  07928
  311598
  6403338.90
  75622575
  03/09/2023
  Nasdaq Stock Market
  American Depository Shares
  07/17/2020
  public offering
  Issuer
  N
  666667
  07/17/2020
  Cash
  N
  The Biotech Growth Trust PLC
  c/o OrbiMed Capital LLC
  601 Lexington Avenue, 54th Floor
  New York
  NY
  10022
  American Depository Shares
  12/22/2022
  229556
  4997434.12
  Additional sales in the last three months by The Biotech Growth Trust PLC (c/o OrbiMed Capital LLC 601 Lexington Avenue, 54th Floor, New York, NY 10022) of American Depository Shares on 12/23/2022. 125,513 American Depository Shares were sold for gross proceeds of $2,866,716.92. OrbiMed Capital LLC is the portfolio manager of The Biotech Growth Trust PLC.
  03/09/2023
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, portfolio manager for The Biotech Growth Trust PLC